首页> 外文OA文献 >Fatal Cytomegalovirus Pneumonia and Associated Herpes Virus Infection in a Relapsed/Refractory Multiple Myeloma Patient Treated with Bortezomib plus Dexamethasone
【2h】

Fatal Cytomegalovirus Pneumonia and Associated Herpes Virus Infection in a Relapsed/Refractory Multiple Myeloma Patient Treated with Bortezomib plus Dexamethasone

机译:硼替佐米联合地塞米松治疗复发/难治性多发性骨髓瘤患者的致命性巨细胞病毒性肺炎和相关疱疹病毒感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple myeloma (MM) remains a largely incurable disease in the long term despite positive responses to first-line chemotherapy. Herein we report the case of a 68-year-old woman who died following treatment with bortezomib plus dexamethasone for refractory MM. The combination was associated with significant antitumor activity, but bacterial pneumonia/sepsis was followed by bilateral cytomegalovirus pneumonia with herpes simplex co-infection, and this was almost certainly the cause of death. Physicians need to pay careful attention when treating patients with refractory MM with bortezomib plus dexamethasone, and to be mindful that antiviral therapy may be needed in some cases.
机译:尽管对一线化疗有积极反应,但从长远来看,多发性骨髓瘤(MM)仍是一种基本无法治愈的疾病。本文报道了一名68岁妇女在接受硼替佐米联合地塞米松治疗难治性MM后死亡的病例。联合使用具有显着的抗肿瘤活性,但细菌性肺炎/败血症后是双侧巨细胞病毒性肺炎并伴有单纯疱疹感染,这几乎肯定是死亡的原因。硼替佐米联合地塞米松治疗难治性MM的医师需要特别注意,并注意在某些情况下可能需要抗病毒治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号